Table 2. Angiographic and procedural characteristics.
| n = 119 (100%) | |
|---|---|
| Radial access, n (%) | 77 (64.7) |
| Angiography, n (%) | |
| 1VD | 53 (44.5) |
| 2VD | 43 (36.1) |
| 3VD | 22 (18.5) |
| Perforated vessel, n (%) | |
| LM | 5 (4.2) |
| LAD | 58 (48.7) |
| LCx | 22 (18.5) |
| RCA | 31 (26.1) |
| SVG | 9 (7.6) |
| Lesion classification according to ACC/AHA, n (%) | |
| Type A | 4(3.4) |
| Type B | 37(31.1) |
| Type B/C | 31(26.1) |
| Type C | 47 (39.5) |
| Ellis classification, n (%) | |
| Type 1 | 39 (32.8) |
| Type 2 | 28 (23.5) |
| Type 3 | 52 (43.7) |
| Type of stenosis, n (%) | |
| De-novo | 109 (91.6) |
| In stent restenosis | 10 (8.4) |
| Chronic total occlusion | 7 (5.9) |
| Bifurcation | 17 (14.3) |
| Severe calcification | 36 (30.3) |
| Tortuosity | 13(10.9) |
| Degree of stenosis, (%), mean, SD | 88.3 ± 11.5 |
| Length of stenosis, (mm), mean, SD | 27.5 ± 14.4 |
| Lesion predilation, (%) | 100 (84.0) |
| Predilation balloon maximal pressure (atm.), mean, SD | 15.1 ± 4.6 |
| Stent deployment maximal pressure (atm.), mean, SD | 14.8 ± 2.9 |
| Maximal stent diameter (mm), mean, SD | 3.4 ± 0.8 |
| Total stent length (mm), mean, SD | 26.5 ± 8.6 |
| Stent postdilation (%) | 41 (34.5) |
| Direct cause of perforation, n (%) | |
| Balloon dilatation | 17 (14.3) |
| Drug eluting stent implantation | 83 (69.7) |
| Bare metal stent implantation | 11 (9.2) |
| Bioresorbable vascular scaffolds implantation | 5 (4.2) |
| Rotablation | 13 (10.9) |
| Treatment of rupture before cover stent implantation, n (%) | |
| Prolonged balloon dilatation | 40 (33.6) |
| Transcatheter fat embolization | 2 (1.7) |
| Non covered stent implantation | 10 (8.4) |
| Type of covered stent, n (%) | |
| Graftmaster | 51 (42.9) |
| Direct-Stent | 2 (1.7) |
| BeGraft | 6 (5.0) |
| PK Papyrus | 55 (46.2) |
| Aneugraft Dx | 5 (4.2) |
| Covered stent data, mean, SD | |
| Length, (mm) | 18.8 ± 4.3 |
| Diameter, (mm) | 3.2 ± 0.5 |
| Pressure, (atm) | 15.2 ± 4.1 |
| Inflation time, (s) | 21.0 ± 24.8 |
| Number of covered stent per patient, mean, SD | 1.1 ± 0.4 |
| Number of non covered stents per patients, mean, SD | 1.2 ± 0.9 |
| Vascular complication, n (%) | |
| Dissection | 28 (23.5) |
| No-reflow | 8 (6.7) |
| TIMI-3 post PCI, n (%) | 100 (84.0) |
| IVUS, n (%) | 6 (5.0) |
| Glycoprotein IIb/IIIa inhibitors administration, n (%) | 10 (8.4) |
| Protamine sulphate administration, n (%) | 20 (16.8) |
VD- vessel disease, LM- left main, LAD- left anterior descending artery, LCx- left circumflex artery, RCA- right coronary artery, SVG–saphenous vain graft, SD—standard deviation, PCI—percutaneous coronary intervention, TIMI—Thrombolysis In Myocardial Infarction, IVUS- intravascular ultrasound.